Jessica N. Abraham | Designer. Writer. Publicist.

19+ Years of Expertise in Digital Marketing, Social Branding and Public Relations.

  • Home
  • Contact
  • About
  • Home
  • Contact
  • About

No Widgets found in the Sidebar Alt!

  • MedTech, HealthTech, Benzinga, BioSig Technologies, BioPharmaceuticals, Jessica Abraham, Jessica N Abraham,
    Business,  Benzinga,  Biotechnology,  Health,  Technology

    MedTech Company BioSig Technologies Deploys Disruptive Technology To Improve Arrhythmia Care

    April 7, 2022 /

    This article was previously published to Benzinga. Arrhythmia is a heart condition that causes it to beat either too fast, or irregularly. It’s triggered by abnormal electrical activity and affects the heart’s rhythm, leading it to beat out of sync with the rest of the body.  Not every patient experiences arrhythmia in the same way, so it’s sometimes necessary for doctors to provide each patient with a personalized approach to treatment and recovery.  Lifestyle choices and comorbidities, medication, stress and environmental factors can cause the heart to beat out of sync. The world is experiencing an uptick in arrhythmia cases linked to the after effects of COVID-19. Atrial fibrillation (AFib) is the…

    read more
    Jessica N. Abraham Comments Off on MedTech Company BioSig Technologies Deploys Disruptive Technology To Improve Arrhythmia Care

    You May Also Like

    LG, Google, Strategic Partnership, Video Games, Gaming, OLED, Gaming Markets, Xbox, PS5, Web 6.0, Web 5.0, Cloud Gaming, Vizio, Sports Programming, Cord Cutting, webOS, Smart TVs, Stadia, Stadia Gaming, Google TV, webOS 6.0, webOS 5.0, LG Electronics Home Entertainment Company, Lee Sang-woo, Business Strategy, Cyberpunk 2077, NBA 2K21, NBA 2K22, Assassin's Creed Valhalla, Watch Dogs Legion, Independent Games, 4k, HDR, XBox Series X, Sony, Jessica N Abraham, Jessica Abraham, tEQlife, News Break, Gaming Industry, FAANG,

    LG and Google Partner, Bringing Stadia Gaming to OLED | Could outperform Xbox, PS5 in Global Gaming Markets

    January 25, 2021
    DISC Insights, DISC Personality, Personality Type, Corporate Culture, Employee Relations, Persona, Behavioral Analysis, Coaching, Dominance, Influence, Hiring Cycles, Recruitment, Talent Acquisition, Onboarding, Team Building, Leadership, Workforce Optimization, Corporate Development, Business Development, Business Expansion, Growth, Team Building, Culture, Building Remote Teams, Compliances, Roles, Infrastructure, Differences in Opinion,

    Using DISC for Building Global Markets, Part 1

    January 19, 2019
    iot, m2m, drone, fog computing, edge computing, smart home, smart city, connected home, smart transportation, wireless, big data, iot power, cloud computing, infrastructure, security, cybersecurity, manufacturing, supply chain, IIoT, industrial IoT, autonomous

    A Connected Experience Capitalizes on the Power of Wi-Fi

    November 30, 2015
  • Statera Pharmaceuticals treatment for Covid-19 Long-Haulers
    Health,  Benzinga,  Biotechnology,  Business,  Finance

    Groundbreaking Studies to Be Conducted on the Effectiveness of Short and Long-term COVID-19 Therapies Inhibiting the Progression of SARS-CoV-2

    October 28, 2021 /

    Previously Published to Benzinga: The following post was written and/or published as a collaboration between Benzinga’s in-house sponsored content team and a financial partner of Benzinga. Statera Biopharma, Inc. (NASDAQ: STAB) recently announced that it has officially received Institutional Review Board (IRB) approval to conduct a Phase 1 pilot study at Loma Linda University Health to evaluate STAT-205 as a treatment in the mitigation of SARS-CoV-2 progression. STAT-205 is a breakthrough immuno-modulator designed to decrease elevated inflammatory responses that are associated with viral infections and inhibit viral replication in human lung cells. Its efficacy was successfully demonstrated during preclinical in vitro studies, where STAT-205 was able to inhibit the replication of…

    read more
    Jessica N. Abraham Comments Off on Groundbreaking Studies to Be Conducted on the Effectiveness of Short and Long-term COVID-19 Therapies Inhibiting the Progression of SARS-CoV-2

    You May Also Like

    Smart Buildings, HVAC, Indoor Air Quality, WiFi, Connected Devices, Internet of things, IoT,

    Delphi360™ to Officially Launch, Improve the Work Environment and Change Indoor Air Quality Forever

    September 7, 2021
    Age-Related Macular Degeneration DRY AMD, Lineage Cell Therapeutics

    Age-Related Macular Degeneration: What is Dry AMD, and How is Lineage Cell Therapeutics Changing the Game?

    August 11, 2021
    CBD Vape, Mood Management, Canopy Growth, Cannabis, Medical Cannabis, Mental Health, Toxic Free Vaping, Healthy Vaping, Health and Wellness,

    Change Your Mood with a Quick Hit: Canopy Growth Launches whisl, First-Ever CBD Vape

    September 15, 2021
  • What is ImQuest, and How is Statera Biopharma using it to Develop New Immune Therapies for Cancer, Infectious Disease and Autoimmune Disorders?
    Business,  Benzinga,  Biotechnology,  Finance,  Health

    What is ImQuest, and How is Statera Biopharma using it to Develop New Immune Therapies for Cancer, Infectious Disease and Autoimmune Disorders?

    September 8, 2021 /

    Previously Published to Benzinga: The following post was written and/or published as a collaboration between Benzinga’s in-house sponsored content team and a financial partner of Benzinga. Statera Biopharma, Inc. (NASDAQ: STAB) — the company formerly known as Cytocom (NASDAQ: CBLI) — recently uplisted to the Nasdaq in lieu of earlier acquisitions involving Cleveland BioLabs and ImQuest Life Sciences, Inc. Last week, the company provided an update on its integration of ImQuest and its plans going forward.  According to Statera, preclinical testing is underway in the screening of second-generation immune therapies using the ImQuest platform for the rapid and accurate assessment of various diseases and how the overall makeup and composition of these diseases interact. The company will look more closely…

    read more
    Jessica N. Abraham Comments Off on What is ImQuest, and How is Statera Biopharma using it to Develop New Immune Therapies for Cancer, Infectious Disease and Autoimmune Disorders?

    You May Also Like

    TMC Net, TMCNet, Technology Marketing Corporations, Technology News, Tech News, Mad Marketer, IoT World, NFV Zone, Virtualization, Unified Communications, Call Centers, Contact Centers, Real-Time Communications Web RTC, Call Accounting, Call Recording, Connected Devices, Web Development, Software Development, Mobile Development, Enterprise Solutions,

    A Case Study: Social Media Listening Needs to Be in Your Marketing Scope for 2016

    December 13, 2015
    Worksport, Terravis, Solar Power Energy, Hydrogen Batteries, Grid-Free energy, Off-grid power

    This Company Has Big Plans for Innovation, Steers Smart Solar Technologies Toward EV-Charging Mobility

    September 29, 2021
    Android,China Wholesale Company,Intel,Kodi,M1 Mini ,PC,MeeGoPad T02,Mini Computer,PC,Technology,Technology News, Windows 10,World's Smallest Android

    Chinavision Releases World’s Smallest Dual Full-Function PC & Android Device

    September 9, 2015
  • Statera Biopharmaceuticals, Groundbreaking Biomedicine Treatment
    Health,  Benzinga,  Biotechnology,  Business,  Finance

    Statera BioPharma: The Ticker Formerly Known as CBLI

    September 7, 2021 /

    Previously Published to Benzinga: The following post was written and/or published as a collaboration between Benzinga’s in-house sponsored content team and a financial partner of Benzinga. On September 1, 2021, Cytocom officially became listed as Statera BioPharma, Inc. (NASDAQ: STAB), as it updated its ticker symbol from CLBI to STAB within the Nasdaq markets.  This change in name comes as a natural progression, as the company shifts gears toward placing a more strategic focus on restoring total immune health — including autoimmune and inflammatory diseases, such as fibromyalgia and multiple sclerosis, blood disorders like anemia and lupus, even cancer and various other infectious diseases.  The company began trading as CLBI, last month,…

    read more
    Jessica N. Abraham Comments Off on Statera BioPharma: The Ticker Formerly Known as CBLI

    You May Also Like

    MedTech, HealthTech, Benzinga, BioSig Technologies, BioPharmaceuticals, Jessica Abraham, Jessica N Abraham,

    MedTech Company BioSig Technologies Deploys Disruptive Technology To Improve Arrhythmia Care

    April 7, 2022
    Smart Buildings, HVAC, Indoor Air Quality, WiFi, Connected Devices, Internet of things, IoT,

    Delphi360™ to Officially Launch, Improve the Work Environment and Change Indoor Air Quality Forever

    September 7, 2021
    Statera Pharmaceuticals treatment for Covid-19 Long-Haulers

    Groundbreaking Studies to Be Conducted on the Effectiveness of Short and Long-term COVID-19 Therapies Inhibiting the Progression of SARS-CoV-2

    October 28, 2021
  • Age-Related Macular Degeneration DRY AMD, Lineage Cell Therapeutics
    Business,  Benzinga,  Finance,  Health,  Regenerative Medicine

    Age-Related Macular Degeneration: What is Dry AMD, and How is Lineage Cell Therapeutics Changing the Game?

    August 11, 2021 /

    Previously Published to Benzinga: The following post was written and/or published as a collaboration between Benzinga’s in-house sponsored content team and a financial partner of Benzinga. Age-related macular degeneration (AMD) is a disease originating in the retina, which may worsen over time, according to WebMD. It’s said to be the leading cause of severe, permanent vision loss in people older than 60.  When the macula — the small central portion of the retina — wears down, the light-sensing nerve tissue at the back of the eye begins to deteriorate. While it doesn’t always cause complete blindness, severe vision problems such as loss of central vision may occur. As the condition worsens,…

    read more
    Jessica N. Abraham Comments Off on Age-Related Macular Degeneration: What is Dry AMD, and How is Lineage Cell Therapeutics Changing the Game?

    You May Also Like

    Crypto, Cryptocurrencies, Trading and leveraging bitcoin to trade derivatives via CFDs.

    How to Leverage More Crypto Using CFDs

    December 6, 2021
    Top Fintechs, Best Fintechs, Columbus Ohio,

    BEST FINTECHS IN COLUMBUS, RANKED

    July 21, 2021
    The Vault, Examiner, Social Media, Social Branding, Pets, Families, Fur Babies, Brand Persona, Entertainment, Fun Apps, Mobile App, Apps, Social Network, Contest, Petco, Gift Card, uraPET, Bailey, Ken Braun, Niche Networks, Emotional Support, Technology, Tech News,

    Pet-friendly Social Network, uraPET, to give away $100 Petco gift card

    June 21, 2013
  • Business
  • Technology
  • Career Development
  • Education
  • Entertainment
  • Fashion
  • Relationships
  • Tips
  • Travel
Ashe Theme by WP Royal.